J&J Innovative Medicine

More than 200 million people worldwide are living with an autoantibody disease, which occurs when the body attacks its own cells, tissues and proteins.

Check out this infographic breakdown of the company’s third-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.

From cultural stigma to language barriers, getting necessary treatment can be challenging for these groups. For Mental Health Awareness Month, learn more about what the company is doing to help people surmount unique obstacles to get the resources they need.

Take a look inside the new cutting-edge hub for medical innovation where company scientists and other researchers will collaborate to help find solutions for some of the world’s toughest health challenges.

A life-threatening condition that afflicts young cancer patients. A rare and painful form of pediatric arthritis. Learn about how Johnson & Johnson is innovating to use existing medications to help kids with these illnesses—and meet two women on the forefront of this game-changing work.

Johnson & Johnson’s Brian Woodfall, M.D., was working at a Vancouver clinic in the mid-1990s. That’s where he met Tiko Kerr, who became one of the first patients to take the company’s HIV medicines—and has thrived to this day. For National AIDS Awareness Month, watch as Kerr, Dr. Woodfall and fellow researcher Joss J. De Wet, M.D., reflect on how those treatments have saved lives and continue to evolve, in this moving video.

Check out this infographic breakdown of the company’s second-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.

As global temperatures continue to rise, so too does the incidence of this mosquito-borne virus. For World Neglected Tropical Disease Day, learn the latest about this growing health threat and how Johnson & Johnson is working to combat it.

Over the past few decades, advances in the study and treatment of this inflammatory bowel disease have rapidly accelerated. We spoke to the experts to learn the latest about managing Crohn’s disease—and what other potential breakthroughs are on the horizon.

Check out this infographic breakdown of the company’s first-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.